NCT06003192 Screen Smart: Using Digital Health to Improve HIV Screening and Prevention
| NCT ID | NCT06003192 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital Medical Center, Cincinnati |
| Condition | HIV Infections |
| Study Type | INTERVENTIONAL |
| Enrollment | 63,000 participants |
| Start Date | 2024-12-16 |
| Primary Completion | 2027-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 63,000 participants in total. It began in 2024-12-16 with a primary completion date of 2027-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this interrupted time series quasi-experimental design study is to implement universal opt- out HIV testing and linkage to HIV preventive care in 15-21 year old adolescents visiting the pediatric emergency department (ED). The main question\[s\] it aims to answer are: 1. What is the uptake, reach and effectiveness of universally offered, opt-out HIV screening across pediatric EDs after implementing an adapted version of a tablet-based screening process? 2. What is the successful linkage to comprehensive HIV pre-exposure prophylaxis (PrEP) care using a novel, digital health platform? Participants will 1. Complete the previously developed and validated computerized sexual health screen (cSHS) containing questions regarding their personal sexual health history 2. Have the opportunity to opt-out of clinician-ordered HIV testing 3. Patients meeting CDC criteria for HIV PrEP will be given the opportunity to enroll in the digital health PrEP linkage platform and followed for 3 months after enrollment.
Eligibility Criteria
Inclusion Criteria: * All patients 15-21 years of age visiting a pediatric emergency department. Exclusion Criteria: * Unable to understand English * Critically ill * Cognitively impaired * Altered mental status
Contact & Investigator
Jennifer L Reed, MD, MS
PRINCIPAL INVESTIGATOR
Children's Hospital Medical Center, Cincinnati
Frequently Asked Questions
Who can join the NCT06003192 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 21 Years, studying HIV Infections. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06003192 currently recruiting?
Yes, NCT06003192 is actively recruiting participants. Contact the research team at patricia.cobb@cchmc.org for enrollment information.
Where is the NCT06003192 trial being conducted?
This trial is being conducted at Columbus, United States, Philadelphia, United States, Salt Lake City, United States, Milwaukee, United States.
Who is sponsoring the NCT06003192 clinical trial?
NCT06003192 is sponsored by Children's Hospital Medical Center, Cincinnati. The principal investigator is Jennifer L Reed, MD, MS at Children's Hospital Medical Center, Cincinnati. The trial plans to enroll 63,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.